Initial combination therapy with ambrisentan + tadalafil on pulmonary arterial hypertension‒related hospitalization in the AMBITION trial.

Vachiéry JL, Galiè N, Barberá JA, Frost AE, Ghofrani HA, Hoeper MM, McLaughlin VV, Peacock AJ, Simonneau G, Blair C, Miller KL, Langley J, Rubin LJ, AMBITION Study Group

Open source

DOI
10.1016/j.healun.2018.11.006
Published
2019 Feb
Container
The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.healun.2018.11.006,
  title = {Initial combination therapy with ambrisentan + tadalafil on pulmonary arterial hypertension‒related hospitalization in the AMBITION trial.},
  author = {Vachiéry JL and Galiè N and Barberá JA and Frost AE and Ghofrani HA and Hoeper MM and McLaughlin VV and Peacock AJ and Simonneau G and Blair C and Miller KL and Langley J and Rubin LJ and AMBITION Study Group},
  year = {2019},
  journal = {The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation},
  doi = {10.1016/j.healun.2018.11.006},
  url = {https://doi.org/10.1016/j.healun.2018.11.006}
}

RIS

TY  - JOUR
TI  - Initial combination therapy with ambrisentan + tadalafil on pulmonary arterial hypertension‒related hospitalization in the AMBITION trial.
AU  - Vachiéry JL
AU  - Galiè N
AU  - Barberá JA
AU  - Frost AE
AU  - Ghofrani HA
AU  - Hoeper MM
AU  - McLaughlin VV
AU  - Peacock AJ
AU  - Simonneau G
AU  - Blair C
AU  - Miller KL
AU  - Langley J
AU  - Rubin LJ
AU  - AMBITION Study Group
PY  - 2019
JO  - The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation
DO  - 10.1016/j.healun.2018.11.006
UR  - https://doi.org/10.1016/j.healun.2018.11.006
ER  - 

APA

JL, V., N, G., JA, B., AE, F., HA, G., MM, H., VV, M., AJ, P., G, S., C, B., KL, M., J, L., LJ, R., & Group, A. S. (2019). Initial combination therapy with ambrisentan + tadalafil on pulmonary arterial hypertension‒related hospitalization in the AMBITION trial.. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation. https://doi.org/10.1016/j.healun.2018.11.006

Source records